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Abstract
Currently, separate measures are used to estimate the impact of animal diseases on mortal-
ity and animal welfare. This article introduces a novel metric, the Welfare-Adjusted Life Year
(WALY), to estimate disease impact by combining welfare compromise and premature
death components. Adapting the Disability-Adjusted Life Year approach used in human
health audits, we propose WALY as the sum of a) the years lived with impaired welfare due
to a particular cause and b) the years of life lost due to the premature death from the same
cause. The years lived with impaired welfare are the product of the average duration of each
welfare impediment, reflecting the actual condition that compromises animal welfare, the
probability of an incident case developing and impaired welfare weights, representing the
degree of impaired welfare. The years of life lost are calculated using the standard expected
lifespan at the time of premature death. To demonstrate the concept, we estimated WALYs
for 10 common canine diseases, namely mitral valve disease, dilated cardiomyopathy,
chronic kidney disease, diabetes mellitus, atopic dermatitis, splenic haemangiosarcoma,
appendicular osteosarcoma, cranial cruciate ligament disease, thoracolumbar intervertebral
disc disease and cervical spondylomyelopathy. A survey of veterinarians (n = 61) was con-
ducted to elicit impaired welfare weights for 35 welfare impediments. Paired comparison
was the primary method to elicit weights, whereas visual analogue scale and time trade-off
approaches rescaled these weights onto the desired scale, from 0 (the optimal welfare
imaginable) to 1 (the worst welfare imaginable). WALYs for the 10 diseases were then esti-
mated using the impaired welfare weights and published epidemiological data on disease
impacts. Welfare impediment “amputation: one limb” and “respiratory distress” had the low-
est and highest impaired welfare weights at 0.134 and 0.796, rescaled with a visual ana-
logue scale, and 0.117 and 0.857, rescaled with time trade-off. Among the 10 diseases,
thoracolumbar intervertebral disc disease and atopic dermatitis had the smallest and
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greatest adverse impact on dogs with WALYs at 2.83 (95% UI: 1.54–3.94) and 9.73 (95%
uncertainty interval [UI]: 7.17–11.8), respectively. This study developed the WALY metric
and demonstrated that it summarises welfare compromise as perceived by humans and
total impact of diseases in individual animals. The WALY can potentially be used for prioriti-
sation of disease eradication and control programs, quantification of population welfare and
longitudinal surveillance of animal welfare in companion animals and may possibly be
extended to production animals.
Introduction
Diseases negatively affect individual companion animals in three ways, by compromising the
welfare of the animal, resulting in premature death, or both. Historically, death-related statis-
tics, such as fatality and survival time, have been used to assess the impact of a disease on
affected companion animals [1–4]. However, while some diseases such as osteosarcoma in
dogs [1, 5] and injection-site sarcomas in cats [6], have a high fatality rate and substantially
shorten the lifespan of animals, others, such as dermatological diseases, can compromise the
welfare of animals without substantially shortening their lives. These traditional, mortality-
based epidemiological statistics mentioned above fail to capture the impact of these disease
states on animal welfare.
Realising this, approximately three decades ago, researchers started to assess the impact of
disease on welfare in companion animals [7]. Most of the instruments developed to evaluate
the welfare of diseased animals focus on a single specific health condition, such as cardiac dis-
ease [8, 9], cancer [10, 11] and skin disease [12–14]. This is a weakness since multiple disorders
and co-morbidities among diseases are commonly encountered in practice. Moreover, using
these instruments, the comparison of the severity of welfare compromise between one health
condition and another is crude if not impractical. Although some generic instruments can be
used to assess the welfare of animals with different health conditions [15, 16], to the authors’
best knowledge, none has been used for quantifying the degree of impaired welfare caused by
different diseases. That said, an attempt to measure the severity of canine inherited diseases
was developed by Asher et al. and named the Generic Illness Severity Index for Dogs [17]. Col-
lins et al. incorporated this index into a Breed-Disorder Welfare Impact Score to quantify the
impact of some inherited diseases on dog welfare [18]. However, the four aspects of the index,
namely, prognosis, treatment, complications, and behavioural impact were not weighted in
the index calculation by the degree of impact on welfare.
It is apparent that, depending on the disease, a disease can adversely impact on the welfare
or the lifespan of the animals, and that, for many diseases, there is negative impact on both.
However, although human medicine and public health have addressed an equivalent deficit in
audits of wellbeing more than 30 years ago [19], a framework that combines these two ele-
ments has not been developed for animals. Foreseeing the need to account for increasing
health loss due to long-term disability caused by non-communicable diseases, such as diabetes
and depression, in health measurement, the Harvard School of Public Health and the World
Health Organization (WHO) launched the Global Burden of Disease (GBD) project in 1994
[20]. The GBD project introduced a new metric called Disability-Adjusted Life Year (DALY)
to measure the burden of disease caused by not only premature death but also impaired health.
The DALY gives a single value that denotes the loss of health caused by both disability and pre-
mature death for each of the diseases examined. The unit used in DALY is time (in years), and
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DALYs are the sum of the years lived with disability and the years of life lost due to premature
death. The DALY considers disability as a partial loss of health and death as a complete loss of
health. As the degree of health impairment differs between disabilities, disability weights, rang-
ing from 0 to 1, account for this variation in DALY calculation, such that 0 means no health
loss (i.e. full health) and 1 denotes complete health loss equivalent to death.
The purpose of the current study was to adapt the DALY framework to develop a novel
metric, the Welfare-Adjusted Life Year (WALY), to estimate the impact of individual diseases
or other causes, such as non-ideal environment or practices, in animals by considering both
the impaired welfare and the premature death. We introduce the WALY specifically, in this
case for dogs, as a new framework to quantify the total impact of a particular cause (an event
or condition), such as a disease or a practice to animals, by combining the duration of
impaired welfare and the potential life lost due to premature death caused by the same cause.
We used 10 common canine diseases to illustrate how WALY can be applied. For each of the
10 diseases, veterinarians were asked to provide data that permitted estimation of the impaired
welfare weights (IWWs), equivalent to the disability weights in DALY. Here we describe the
approach used to estimate IWWs for the selected canine diseases. The IWWs elicited were
then used to calculate WALYs for these diseases. Finally, we consider the strengths and limita-
tions of the approaches and discuss how to improve the methodology and apply the WALY in
the future.
Materials and methods
Welfare-adjusted life year
WALY is the sum of two components (Eq 1): (a) the years lived with impaired welfare (YLIW)
due to a particular cause and (b) the years of life lost (YLL) due to premature death from the
same cause.
WALY ¼ YLIWþ YLL ðEq 1Þ
YLIW for a given affected animal is the duration of the impaired welfare weighted by the
severity of welfare compromise (i.e., IWW). YLIWs equal the sum, across each welfare impedi-
menti, i = 1, . . ., n, of a cause, of the product of the probability (Pi) of an incident case develop-
ing each welfare impediment (i.e., the actual physical or physiological condition that
compromises the welfare resulting from the cause), with the average duration in years (Di) and
its IWWi. YLLs are calculated as the standard life expectancy at age of death (L) (Eq 3).
YLIWs ¼
Pn
i¼1Pi  Di  IWWi ðEq 2Þ
YLL ¼ L ðEq 3Þ
To avoid simply combining impaired welfare and premature death in the equation, and in a
bid to quantify and incorporate the welfare impact of not living the years lost caused by prema-
ture death into the WALY calculation, weighted YLLs, defined as the YLL value multiplied by
the IWW of death, were also calculated. Weighted WALY is, therefore, the sum of YLIWs and
weighted YLLs.
Selection of diseases and welfare impediments
Based on the availability of information needed, as mentioned above, to calculate WALYs in
the literature, 10 common diseases in dogs were included the current study. These were mitral
valve disease, dilated cardiomyopathy, chronic kidney disease, diabetes mellitus, atopic
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dermatitis, splenic haemangiosarcoma, appendicular osteosarcoma, cranial cruciate ligament
disease, thoracolumbar intervertebral disc disease and cervical spondylomyelopathy.
The welfare impediments were identified for each disease by consulting the literature and
veterinary specialists (PB, PYC and others). A welfare impediment could be a health condition,
a sign or a treatment related to the disease, that compromises dog welfare to different extents.
One disease can have one or more welfare impediments. For example, dogs having mitral
valve disease might have 1) “mild-moderate heart failure (with treatment)” or 2) “severe heart
failure (with treatment)”, and most of them would need 3) “frequent veterinary visits (for fear-
ful dogs)”. Each of these three is accompanied by changes that compromise dog welfare to dif-
ferent degrees. Note that the same welfare impediment can be found in different diseases. For
example, “mild-moderate heart failure (with treatment)” and “severe heart failure (with treat-
ment)” are welfare impediments arising from both mitral valve disease and dilated cardiomy-
opathy. Furthermore, although the likelihood of many welfare impediments remains similar
throughout the disease course, the likelihood of others might change. Therefore, we identified
key sequelae for each disease to allow the changes in the WALY calculation. Considerations
here included the disease itself, different stages of the disease, the treatment or disease compli-
cations. Death was included as a welfare impediment for diseases resulting in mortality. A
complete list of diseases, their disease sequelae and welfare impediments are shown in Table 1.
Two additional welfare impediments (“severe anaemia” and “wheelchair some hours a day”)
were incorporated because they are related to some welfare impediments identified. Over-
weight, obesity and fever were included arbitrarily. In total, 35 unique welfare impediments
were considered in this study.
Estimation of the impaired welfare weights
An IWW for a welfare impediment is a number on a scale from 0 to 1 that denotes the severity
of welfare compromises associated with the impediment. A value of 0 denotes the most opti-
mal welfare that one can imagine, and a value of 1 denotes the worst welfare that one can imag-
ine. The IWWs were derived based on the responses of veterinarians to a hard-copy
questionnaire (S1 File).
Ethics approval for the procedures was granted by the University of Sydney Human
Research Ethics Committee (Approval number: 2017/050).
Questionnaire design. Four modules were designed to be used in the questionnaire.
However, as discussed below, the inclusion of three of the modules for IWW valuation
depended on the version of the questionnaire administered. One module collected informa-
tion about demographics of the participant, such as gender, age, graduation year, and the ani-
mal species the respondent currently worked with (dogs/cats, equines, unusual pets, livestock,
captive wildlife, wildlife and laboratory/experimental animals). The other three modules con-
tained questions based on three techniques used to evaluate the severity of the welfare impedi-
ments: paired comparison, visual analogue scale and time trade-off, respectively. Paired
comparison generated preliminary IWWs for the 35 welfare impediments, a relative ranking
of welfare impediments, where the resulting distances between preliminary IWWs emerge on
an arbitrary scale. Using the IWW values of the same five welfare impediments generated by a
visual analogue scale and time trade-off, visual analogue scale and time trade-off modules
anchored preliminary IWWs onto the desired scale, 0 to 1, separately to allow comparison of
the final IWW values between the two methods. The five welfare impediments selected were:
“anaemia: mild”, “musculoskeletal problems: one limb, mild”, “diarrhoea: two times or more a
day”, “cancer: lung metastasis with/without having metastasis in other parts of the body”
and “respiratory distress”. These five were selected with the intention of covering welfare
Welfare-Adjusted Life Years (WALY)
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Table 1. Sequelae and welfare impediments identified for the ten diseases included in WALY study.
Disease Disease sequela Welfare impediment
Mitral valve disease Mitral valve disease with signs of heart failure Mild-moderate heart failure (with treatment)
Severe heart failure (with treatment)
Frequent veterinary visits (for fearful dogs)
Death Death
Dilated cardiomyopathy Dilated cardiomyopathy with signs of heart failure Mild-moderate heart failure (with treatment)
Severe heart failure (with treatment)
Frequent veterinary visits (for fearful dogs)
Death Death
Chronic kidney disease Chronic kidney disease Vomiting: two times or more a day
Diarrhoea: two times or more a day
Polyuria and polydipsia
Anaemia: moderate
Lethargy and loss of appetite
Death Death
Diabetes mellitus Diabetes mellitus: pre-diagnosis Polyuria and polydipsia
Severe vision impairment and blindness
Anaemia: mild
Abdominal pain or discomfort
Diabetes mellitus: stable phase Frequent veterinary visits (for fearful dogs)
Severe vision impairment and blindness
Abdominal pain or discomfort
Frequent subcutaneous injections by carers at home
Diabetic ketoacidosis Vomiting: two times or more a day
Diarrhoea: two times or more a day
Lethargy and loss of appetite
Polyuria and polydipsia
Anaemia: mild
Abdominal pain or discomfort
Respiratory distress
Death Death
Atopic dermatitis Atopic dermatitis Pruritus and discomfort: mild
Pruritus and discomfort: moderate
Pruritus and discomfort: severe
Frequent veterinary visits (for fearful dogs)
Splenic haemangiosarcoma Splenic haemangiosarcoma: pre-diagnosis Abdominal pain or discomfort
Cancer: lung metastasis with/without having metastasis in
other parts of the body
Cancer: diagnosis and primary therapy Cancer: diagnosis and primary therapy
Frequent veterinary visits (for fearful dogs)
Cancer: lung metastasis with/without having metastasis in other
parts of the body
Cancer: lung metastasis with/without having metastasis in
other parts of the body
Abdominal pain or discomfort
Frequent veterinary visits (for fearful dogs)
Death Death
Appendicular osteosarcoma Osteosarcoma: pre-diagnosis Musculoskeletal problems: one limb, severe
Cancer: diagnosis and primary therapy Cancer: diagnosis and primary therapy
Amputation: one limb
Frequent veterinary visits (for fearful dogs)
(Continued)
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Table 1. (Continued)
Disease Disease sequela Welfare impediment
Cancer: lung metastasis with/without having metastasis in other
parts of the body
Cancer: lung metastasis with/without having metastasis in
other parts of the body
Amputation: one limb
Frequent veterinary visits (for fearful dogs)
Death Death
Cranial cruciate ligament disease Cranial cruciate ligament disease: pre-diagnosis Musculoskeletal problems: one limb, mild
Musculoskeletal problems: one limb, moderate
Musculoskeletal problems: one limb, severe
Cranial cruciate ligament disease: recovery phase Musculoskeletal problems: one limb, mild
Musculoskeletal problems: one limb, moderate
Musculoskeletal problems: one limb, severe
Cranial cruciate ligament disease: stable phase Musculoskeletal problems: one limb, mild
Musculoskeletal problems: one limb, moderate
Musculoskeletal problems: one limb, severe
Thoracolumbar intervertebral disc
disease
Thoracolumbar intervertebral disc disease: pre-diagnosis Spinal hyperesthesia: mild
Spinal hyperesthesia: more severe
Ataxia, paraparesis or tetraparesis
Non-ambulatory paraparesis or paraplegia
Urinary incontinence (upper motor neuron)
Urinary incontinence (lower motor neuron)
Thoracolumbar intervertebral disc disease: recovery phase Spinal hyperesthesia: mild
Ataxia, paraparesis or tetraparesis
Non-ambulatory paraparesis or paraplegia
Urinary incontinence (upper motor neuron)
Urinary incontinence (lower motor neuron)
Thoracolumbar intervertebral disc disease: stable phase Spinal hyperesthesia: mild
Ataxia, paraparesis or tetraparesis
Non-ambulatory paraparesis or paraplegia
Urinary incontinence (upper motor neuron)
Urinary incontinence (lower motor neuron)
Thoracolumbar intervertebral disc disease: reoccurrence
episode
Spinal hyperesthesia: mild
Spinal hyperesthesia: more severe
Ataxia, paraparesis or tetraparesis
Non-ambulatory paraparesis or paraplegia
Urinary incontinence (upper motor neuron)
Urinary incontinence (lower motor neuron)
Death Death
Cervical spondylomyelopathy Cervical spondylomyelopathy: pre-diagnosis Spinal hyperesthesia: mild
Spinal hyperesthesia: more severe
Ataxia, paraparesis or tetraparesis
Non-ambulatory tetraparesis or tetraplegia
Cervical spondylomyelopathy: recovery phase Spinal hyperesthesia: mild
Ataxia, paraparesis or tetraparesis
Non-ambulatory tetraparesis or tetraplegia
Death Death
The compromise eventuating from frequent veterinary visits reflects aversive procedures and is especially relevant for dogs that are fearful of transport and veterinary
personnel, clinics and procedures.
https://doi.org/10.1371/journal.pone.0202580.t001
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compromise across a range of severity. The questionnaire ended with a question asking if the
participant had cared for their own or their family’s dogs for any of the health conditions
included in the study.
Paired comparison is a process of comparing two options and judging which the respon-
dents consider more appropriate. For the paired comparison module, each question presented
two hypothetical scenarios for dogs with different welfare impediments and the participant
was asked to specify which dog, in their opinion, had better welfare. A visual analogue scale is
a measurement instrument that allows respondents to rate subjective characteristics or atti-
tudes across a defined range. Visual analogue scales have been adapted for disability weight
elicitation in humans with the advantage of good comprehensibility. For the visual analogue
scale module, participants were first asked to rank the five selected welfare impediments
according to the severity of the welfare compromise, and second asked to place them onto a
scale from 0 to 100 (with zero being the worst imaginable welfare and 100 being the optimal
welfare). Originally used in health economics [21], the so-called time trade-off is a technique
for evaluation of quality of life under specific health conditions by measuring the length of life
that participants would trade for full welfare. In the time trade-off module of the current ques-
tionnaire, the participants were able to prevent a hypothetical dog from living with one of the
five anchoring welfare impediments for the next 10 years and allow it to live with optimal
health and welfare. So, in exchange for optimal welfare, the dog would live for a shorter period,
with the length of optimal welfare being nominated by participant depending on their opinion
about the severity of the welfare compromise caused by the welfare impediment. Generally
speaking, the more the condition impaired welfare, the shorter the life with optimal welfare
should be lived. The participants could choose not to trade if, in their opinion, there was no
difference between living with the welfare impediment described and living with optimal
welfare.
Generation of lay descriptions for the welfare impediments. Apart from “death”, lay
descriptions for each of the welfare impediments were derived from consultations with special-
ists (PB and PYC) and an animal welfare scientist (PM) during the questionnaire design pro-
cess and were used in the questionnaires without specifying the names of the welfare
impediments. Using the Five Domains animal welfare framework [22], negative welfare expe-
riences caused by a welfare impediment were classified into one of the following domains:
nutrition, environment, health, behaviour (that adopted a behavioural framework with 5 cate-
gories, namely, maintenance, elimination, locomotion, ingestion and social behaviour, pro-
posed by Asher et al. [18]) and affective (mental) state. The physical/functional experiences
said to affect at least half of the cases were used to compose the lay description with a limit of
50 words for each welfare impediment. An example of a lay description and the negative wel-
fare experiences classified by the Five Domains is shown in Table 2 and a complete version for
all welfare impediments can be found in S1 Table.
Sample size and questionnaire type. Assuming the expected population standard devia-
tion to be 25 (i.e., one-quarter of the visual analogue scale) and using the standard sample size
formula to estimate a single mean, the study required a sample size of 28 to estimate a mean
value for each welfare impediment on the visual analogue scale with 95% confidence and a pre-
cision of 10. Therefore, we aimed to attain a minimum of 30 responses for each welfare imped-
iment in the paired comparison module, the visual analogue scale module and the time trade-
off module. To achieve this whilst limiting the questionnaire completion time to 15 minutes,
three versions of the questionnaire were designed: (A) the visual analogue scale module and 16
paired comparison questions in the paired comparison module, (B) the time trade-off module
and 16 paired comparison questions in the paired comparison module, and (C) both the visual
analogue scale and the time trade-off modules and 11 paired comparison questions in the
Welfare-Adjusted Life Years (WALY)
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paired comparison module. As mentioned above, all questionnaires contained the demograph-
ics module and the question about participants’ personal experience with certain health condi-
tions in dogs. Questionnaires A and B were expected to be completed by 10 participants each,
and Questionnaires C by 20 participants each. In total, a minimum of 40 participants were
needed for this study.
Participants. Participants were required to be veterinarians registered in Australia or
New Zealand and were recruited during the 2017 Australian Veterinary Association Annual
Conference on 5th and 6th June 2017 in Melbourne, Australia. Each participant received an AU
$20 gift card for participating in the survey. Random numbers were used to allocate the three
questionnaire versions among the participants.
Statistical analysis
Responses to the questionnaire were encoded in Microsoft Excel 2010 (Microsoft Corp. Red-
mond, Washington, United States), and descriptive statistics of the demographics of partici-
pants, IWW generation and WALY calculation were conducted in R version 3.3.0 (R Core
Team).
Generation of impaired welfare weights. The paired comparison data were analysed
using probit regression [23]. A pooled dataset of paired comparison questions was structured
in a specific format with each question representing a row (S2 Table). The 1st welfare impedi-
ment in the question was marked as 1, the 2nd welfare impediment in the question marked as
-1, and other welfare impediments not included were 0. A binary variable was created based
on the participants’ responses at 1 if the first welfare impediment was chosen, or 0 if the second
welfare impediment was chosen. Probit regression analyses were run with the participant
Table 2. An example of lay descriptions and welfare compromises classified by Five Domains of welfare impediments.
Welfare
impediment
Mild-moderate heart failure (with treatment)
Lay description After longer periods of intense physical activity, Dog X is more likely than usual to experience tiredness, weakness and laboured breathing. As
such, the dog exercises and plays somewhat less. Also, the dog sometimes coughs.
Welfare
compromise
Five Domain Welfare compromises affecting 50% of the cases Welfare compromises affecting 10% but <50% of the cases
Nutrition - Sodium-restricted diet is not provided.
Environment - Cold weather and night can exacerbate the coughing. - Hot and humid weather exacerbates the respiratory signs of heart
failure.
Health - Mild to moderate heart failure
- Some decrease in capacity to endure intense physical
activities (e.g. exercise, running, fetching and playing)
- Coughing, particularly during and after longer periods of
intense physical activities
- Laboured breathing after longer periods of intense physical
activities, such as extended exercise and longer walks.
- Weight loss
- Laboured breathing after moderate exercise or moderate walks
- Ascites
- Syncope
Behaviour - Undertakes somewhat fewer intense physical activities than
usual
- Somewhat less interaction with people, other dogs or
animals than usual
- Eats less than usual; refuses regular food
- Cannot sleep well due to coughing or trouble breathing during the
night
- Physical restriction is enforced by the carer: the dog exercises, plays
and interacts with people, other dogs or animals less than usual
Affective
state
- Some discomfort
- Appears tired and weak more easily than usual after longer
periods of intense physical activities
- Shortness of breath after longer periods of intense physical
activities
- Some loss of appetite
- Fewer positive affective states due to physical restriction than usual
- Sometimes restless at night
https://doi.org/10.1371/journal.pone.0202580.t002
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response as the outcome variable and all the welfare impediments as dummy variables (i.e., 1
and -1).
IWWs of the five welfare impediments using the results from the visual analogue scale and
time trade-off questions were calculated separately using the following formulae (Eqs 4 and 5),
where IWWVAS and IWWTTO represent the IWWs based on the visual analogue scale (VAS)
and time trade-off (TTO) questions, respectively, and n is the number of responses.
IWWVAS ¼
Pn
i¼1ð1  
welfare impedimenti
100
Þ
n
ðEq 4Þ
IWWTTO ¼
Pn
i¼1ð1  
welfare impedimenti
10
Þ
n
ðEq 5Þ
The mean IWWs were compared descriptively and using a 2-sample t-test between two cat-
egories of the binary demographics that are likely to relate to the evaluation of IWWs and had
at least 20 participants in both groups. Demographics that had numeric results were grouped
into binary with the median value as the cut-off value. These binary demographics included
gender (male or female) [24, 25], age (<36 or36), graduation year (<2005 or2005) [24],
special interest in small animal medicine and/or surgery (yes or no), and working with live-
stock (yes or no) [25, 26]. A P-value of<0.05 was considered to be significant.
To project the results from the probit regression model on an IWW scale ranging from 0 to
1, we ran locally weighted scatterplot smoothing (loess) regression models of the probit regres-
sion coefficients from the paired comparison valuation method versus the logit transformed
IWW values from the visual analogue scale and time trade-off [27]. The span values started
with 0.75 (range from 0 to 1) and, if needed, the starting span value was adjusted, to ensure
model convergence. We then predicted logit transformed IWWs for each of the probit coeffi-
cients from the loess fit. To change the scale and obtain values ranging between 0 and 1, an
inverse logistic transformation of these predicted IWW was applied.
The uncertainty of the predictions of the loess regression model was propagated using
Monte Carlo simulations [28]. For each mapped IWW, 100,000 simulations were drawn from
a logit-normal distribution specified by the predicted IWW and standard error. The resulting
uncertainty distribution was summarised by its mean and a 95% uncertainty interval (UI)
defined as the distribution’s 2.5th and 97.5th percentile [28].
Welfare-adjusted life year calculation. Using information from the peer-reviewed litera-
ture (Table 3), the life table from Inoue et al. [29] and IWWs elicited by our study, YLIWs (Eq
2), YLLs (Eq 3), weighted YLLs, WALY and weighted WALY were calculated for the ten dis-
eases. To estimate the YLLs for the 10 canine diseases, the age of premature death for each dis-
ease was estimated using the average age at diagnosis and the average survival time for a
disease and, using the derived age of death, YLL was estimated by implementing a linear inter-
polation using the life table. The proportional contributions of YLIWs and YLLs to WALYs
were calculated.
The uncertainty of YLIW, YLL and WALY was propagated using 100,000 Monte Carlo sim-
ulations and results were presented as the mean and 95% UI of the resulting uncertainty distri-
butions using “mc2d” [30] and “FERG” [31] packages in R.
Results
Welfare comprise weight generation
Demographics of respondents. There were 61 participants in total, of whom 41 (67%)
were females and 20 (33%) were males. The median age was 36 (interquartile range: 29–51;
Welfare-Adjusted Life Years (WALY)
PLOS ONE | https://doi.org/10.1371/journal.pone.0202580 September 12, 2018 9 / 24
range: 24–69) years and the median time since graduation was 12 years (interquartile range:
4–28; range: 1–45). Most participants had owned dogs or grown up with dogs (90%). Thirty
(49%) had a special interest in small animal medicine and/or surgery. At the time of complet-
ing the questionnaire, 18 (30%) participants worked with livestock, and only 2 (3%) did not
work at all with dogs and cats. More demographics can be found in S3 Table.
Across the 61 participants, the random allocation of the three questionnaire versions
resulted in completion of the demographics module and the question on participants’ personal
experience with certain dog health conditions by 61 respondents, the visual analogue scale
module by 45 (16 for version A and 29 for version C) and the time trade-off module by 45 (16
for version B and 29 for version C), however for the visual analogue scale and time trade-off
module modules the non-feasible answers of 1 participant each were excluded from the analy-
sis. For the paired comparison module, 828 paired comparison questions were answered by
the 61 respondents excluding three questions that were not completed because two partici-
pants were unable to distinguish the severity of the welfare compromise between the two
options in these questions.
Impaired welfare weights. The five IWWs elicited by the visual analogue scale and time
trade-off followed the same severity order (Table 4) although the distribution of the five IWWs
was greater in the latter than in the former. Generally, the five IWWs were higher for partici-
pants who were female, younger than 36 years, had graduated in 2005 or later, or did not work
Table 3. Peer-reviewed articles used for data extraction for the estimation of welfare-adjusted life year for 10 canine diseases on which the current study focused.
Disease Average age at diagnosis1 Average survival time from time of
diagnosis (years)
Probability of an incident case developing and
duration of welfare impediments in disease
sequelae
Mitral valve disease Borgarelli et al., 2008 [mean: 10.6
(SD2: 2.62)] [32]
Borgarelli et al., 2008 [median: 1.63 (range:
0.03–6)] [32]
Borgarelli et al., 2008 [32]
Dilated cardiomyopathy Martin et al., 2009 [median: 6.67
(IQR3: 4.79–8.54)] [33]
Martin et al., 2009 [median: 0.37 (IQR: 0.08–
1.15)] [33]
Martin et al., 2009 [33]
Chronic kidney disease O’Neill et al., 2013 [median: 12.39
(range: 0.75–19.14)] [34]
O’Neill et al., 2013 [median: 0.62 (95% CI4:
0.31–0.89)] [34]
O’Neill et al., 2013 [34]
Diabetes mellitus Mattin et al., 2014 [median: 9.9
(range: 3.3–17.4)] [35]
Mattin et al., 2014 (median: 1.44) [35] Hess et al., 2000 [36]; Fall et al., 2007 [4]; De
Causmaecker et al., 2009 [37]
Atopic dermatitis Saridomichelakis et al., [median:
2.5 (range: 0.17–8)] [38]
NA5 Rybnı´ček et al., 2009 [39]
Splenic haemengiosarcoma Kahn et al., 2013 [median: 9.9
(range: 7–14.1)] [40]
Estimated using information from Kahn
et al., 2013 [40]
Kahn et al., 2013 [40]; Kim et al., 2007 [41]
Appendicular osteosarcoma Bacon et al., 2008 [median: 8
(range: 1.3–13.2)] [42]
Bacon et al., 2008 [median: 0.71 (95% CI :
0.48–0.94)] [42]
Bacon et al., 2008 [42]
Cranial cruciate ligament
disease
Multiple [43] NA Cabrera et al., 2008 [43]; Stein and Schmoekel 2008
[44]; Voss et al., 2008 [45]; Oxley et al., 2013 [46]
Thoracolumbar
intervertebral disc disease
Aikawa et al., 2012 [median: 5
(range: 1.5–14)] [47]
Multiple [48] Aikawa et al., 2012 [47]; Aikawa et al., 2012 [48];
Fadda et al., 2013 [49]; Salger et al., 2014 [50]
Cervical spondylomyelopathy McKee et al., 1999 [median: 7
(range: 3–11)] [51]
Estimated using information from da Costa
et al., 2008 [52] and de Decker et al., 2009
[53]
Fadda et al., 2013 [49]; McKee et al., 1999 [51]
1: Decimal place depended on the results in the articles cited.
2: Standard deviation.
3: Interquartile range.
4: Confidence interval.
5: Not applicable.
https://doi.org/10.1371/journal.pone.0202580.t003
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with livestock at the time of completing the questionnaire (Table 5). From the IWWs elicited
using the visual analogue scale, mean IWW for “anaemia: mild” was scored significantly higher
by females than by males (0.25 vs. 0.14); mean IWW of “cancer: lung metastasis with/without
having metastasis in other parts of the body” was scored significantly higher by young gradu-
ates than by older graduates (0.81 vs. 0.70); “diarrhoea: two times or more a day” was scored
significantly lower by veterinarians interested in small animal medicine and/or surgery than
their counterparts (0.42 vs. 0.55); and mean IWW of “musculoskeletal problems: one limb,
mild” was scored significantly higher by veterinarians working with livestock than by those
who did not work with livestock (0.46 vs. 0.31). None of the five mean IWWs using time
trade-off were statistically significant different among respondents across the various demo-
graphic categories.
Two sets of IWWs were generated after anchoring IWWs from the visual analogue scale
and the time trade-off methods, respectively (Fig 1). In theory, the ranked severity of the
welfare impediment elicited by paired comparison should align with ranks generated by
Table 4. The impaired welfare weights (IWWs) for five welfare impediments generated by visual analogue scale (VAS) and time trade-off (TTO) ordered from low-
est to highest.
Welfare impediment IWW (VAS) IWW (TTO)
Mean SD1 Range Mean SD Range
Cancer: lung metastasis with/without having metastasis in other parts of the body 0.759 0.156 0.30–1.00 0.858 0.166 0.30–0.99
Musculoskeletal problems: one limb, mild 0.414 0.169 0.05–0.80 0.386 0.324 0.00–0.99
Anaemia: mild 0.215 0.135 0.03–0.53 0.198 0.260 0.00–0.95
Respiratory distress 0.897 0.094 0.50–1.00 0.917 0.144 0.40–1.00
Diarrhoea: two times or more a day 0.483 0.210 0.15–0.98 0.480 0.326 0.00–0.99
Legends: IWWs range from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable).
1: Standard deviation
https://doi.org/10.1371/journal.pone.0202580.t004
Table 5. The mean impaired welfare weights (IWWs) of subgroups for five welfare impediments generated by visual analogue scale (VAS) and time trade-off
(TTO).
Name Gender Age (year) Graduation year Interest in
small animal
medicine/
surgery
Working with
livestock
Visual analogue scale Female Male <36 36 2005 <2005 No Yes No Yes
Cancer: lung metastasis with/without having metastasis in other parts of the body 0.78 0.72 0.79 0.73 0.81 0.70 0.77 0.75 0.77 0.74
Musculoskeletal problems: one limb, mild 0.44 0.36 0.42 0.41 0.43 0.40 0.39 0.44 0.46 0.31
Anaemia: mild 0.25 0.14 0.21 0.22 0.22 0.21 0.24 0.20 0.22 0.21
Respiratory distress 0.91 0.87 0.90 0.89 0.90 0.89 0.92 0.88 0.92 0.86
Diarrhoea: two times or more a day 0.50 0.45 0.46 0.51 0.48 0.48 0.55 0.42 0.46 0.53
Time trade-off
Cancer: lung metastasis with/without having metastasis in other parts of the body 0.86 0.85 0.89 0.82 0.89 0.82 0.86 0.85 0.87 0.81
Musculoskeletal problems: one limb, mild 0.40 0.36 0.47 0.31 0.45 0.31 0.3 0.46 0.41 0.27
Anaemia: mild 0.20 0.19 0.23 0.17 0.22 0.17 0.18 0.21 0.21 0.13
Respiratory distress 0.91 0.94 0.96 0.88 0.96 0.87 0.93 0.90 0.92 0.89
Diarrhoea: two times or more a day 0.53 0.37 0.56 0.40 0.56 0.39 0.45 0.50 0.50 0.39
Legends: IWWs range from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable).
 Significant difference between the two subgroups based on P-value <0.05.
https://doi.org/10.1371/journal.pone.0202580.t005
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anchoring methods, resulting in a monotonic trend. However, “cancer: lung metastasis with/
without having metastasis in other parts of the body” was rated more severe than “respiratory
distress” in paired comparison but less severe in both of the anchoring methods. Therefore,
additional sets of IWWs elicited using the anchoring IWWs results without welfare impedi-
ment “respiratory distress” or “cancer: lung metastasis with/without having metastasis in other
parts of the body” were built separately and compared (Fig 1). IWWs elicited by loess regres-
sion without including the anchoring welfare impediment “respiratory distress” are displayed
in Table 6. All the IWW results generated by the six models are displayed in S4 Table.
The ranges of the IWWs for the 35 welfare impediments elicited by time trade-off (0.117–
0.857) were wider than those elicited by visual analogue scale (0.134–0.796), with both exclud-
ing “respiratory distress” in the anchoring process. Only one welfare impediment, “cancer:
lung metastasis with/without having metastasis in other parts of the body”, elicited rankings
that differed between these two sets of IWWs. “Death” was the 23rd severest welfare impedi-
ment in both sets of results, with an IWW at 0.562 and 0.558 when anchored by the visual ana-
logue scale and time trade-off, respectively. The IWWs of most of the welfare impediments
that differ only in the level of severity align with their ranking (e.g., the IWWs of “anaemia:
mild”, “anaemia: moderate” and “severe anaemia” anchored by the visual analogue scale were
0.224, 0.693 and 0.795, respectively). However, “overweight” was rated as compromising dog
welfare more than “obesity”, and the same phenomenon was observed for spinal hyperesthesia
in that “spinal hyperesthesia: mild” was rated as compromising dog welfare more than “spinal
hyperesthesia: severe”.
Welfare-adjusted life year results
YLIW, YLL, and WALY results using IWWs from each of the six loess regression models are
shown in S5 Table. The WALY results using IWWs from the time trade-off method, after
excluding the anchoring welfare impediment “respiratory distress” in the model building pro-
cess, appear in Table 7 and Fig 2. The WALYs were very similar for both anchoring methods.
Atopic dermatitis and thoracolumbar intervertebral disc disease had the highest and lowest
WALYs at 9.73 (95% UI: 7.17–11.8) and 2.83 (95% UI: 1.54–3.94), respectively (Table 7). The
WALYs for atopic dermatitis and cranial cruciate ligament disease were composed purely of
YLIWs and the WALY for thoracolumbar intervertebral disc disease was composed mainly of
Fig 1. Comparison of impaired welfare weights anchored by visual analogue scale (black) and time trade-off (grey). Fig 1(a) displays the models
using all the five anchoring welfare impediments, and the models in (b) and (c) excluded “respiratory distress” and “cancer: lung metastasis with/
without having metastasis in other parts of the body”, respectively.
https://doi.org/10.1371/journal.pone.0202580.g001
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Table 6. Impaired welfare weights (IWWs) for the 35 welfare impediments.
Welfare impediment IWW (VAS) IWW (TTO)
Mild-moderate heart failure (with treatment) 0.357 (0.305–
0.411)
0.337 (0.304–
0.372)
Severe heart failure (with treatment) 0.646 (0.524–
0.755)
0.655 (0.575–
0.728)
Cancer: diagnosis and primary therapy 0.728 (0.599–
0.833)
0.752 (0.673–
0.821)
Cancer: lung metastasis with/without having metastasis in other parts of
the body
0.757 (0.679–
0.824)
0.857 (0.823–
0.887)
Musculoskeletal problems: one limb, mild 0.387 (0.332–
0.444)
0.368 (0.332–
0.405)
Musculoskeletal problems: one limb, moderate 0.760 (0.637–
0.858)
0.793 (0.720–
0.854)
Musculoskeletal problems: one limb, severe 0.786 (0.675–
0.872)
0.829 (0.767–
0.879)
Severe vision impairment and blindness 0.602 (0.490–
0.707)
0.604 (0.530–
0.675)
Overweight 0.504 (0.420–
0.588)
0.494 (0.438–
0.550)
Obesity 0.406 (0.348–
0.467)
0.389 (0.350–
0.428)
Spinal hyperesthesia: mild 0.777 (0.661–
0.868)
0.815 (0.749–
0.870)
Spinal hyperesthesia: more severe 0.740 (0.612–
0.843)
0.767 (0.689–
0.833)
Ataxia, paraparesis or tetraparesis 0.504 (0.420–
0.587)
0.494 (0.437–
0.549)
Non-ambulatory paraparesis or paraplegia 0.740 (0.614–
0.843)
0.767 (0.691–
0.833)
Non-ambulatory paraparesis or paraplegia: on wheelchair some hours a
day
0.641 (0.520–
0.750)
0.649 (0.570–
0.722)
Non-ambulatory tetraparesis or tetraplegia 0.795 (0.698–
0.872)
0.846 (0.795–
0.888)
Urinary incontinence (upper motor neuron) 0.747 (0.621–
0.848)
0.776 (0.700–
0.840)
Urinary incontinence (lower motor neuron) 0.783 (0.670–
0.871)
0.825 (0.762–
0.876)
Anaemia: mild 0.224 (0.163–
0.295)
0.203 (0.165–
0.247)
Anaemia: moderate 0.693 (0.565–
0.803)
0.711 (0.629–
0.783)
Anaemia: severe 0.795 (0.696–
0.872)
0.845 (0.793–
0.888)
Pruritus and discomfort: mild 0.560 (0.459–
0.657)
0.556 (0.489–
0.621)
Pruritus and discomfort: moderate 0.748 (0.623–
0.849)
0.778 (0.702–
0.842)
Pruritus and discomfort: severe 0.750 (0.624–
0.850)
0.780 (0.704–
0.843)
Respiratory distress 0.796 (0.713–
0.865)
0.857 (0.815–
0.892)
Polyuria and polydipsia 0.332 (0.282–
0.386)
0.312 (0.279–
0.347)
Vomiting: two times or more a day 0.796 (0.709–
0.866)
0.855 (0.811–
0.892)
(Continued)
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YLIWs. In contrast, the WALYs of other diseases were derived predominantly from YLLs. As
weighted YLLs were approximately 0.56 times of non-weighted YLLs, weighted WALYs were
lower than non-weighted WALYs, apart from for atopic dermatitis and cranial cruciate liga-
ment disease due to no YLLs.
Discussion
To the authors’ knowledge, WALY is the first metric to estimate the total disease impact of
both welfare compromise and premature death in animals. This study created the WALY met-
ric and IWW generation as an adaptation of the DALY metric and disability weight index used
in human medicine, respectively, and generated WALYs for ten canine diseases and estimated
Table 6. (Continued)
Welfare impediment IWW (VAS) IWW (TTO)
Diarrhoea: two times or more a day 0.502 (0.418–
0.586)
0.492 (0.436–
0.548)
Abdominal pain or discomfort 0.741 (0.613–
0.844)
0.768 (0.691–
0.835)
Lethargy and loss of appetite 0.736 (0.609–
0.840)
0.763 (0.685–
0.830)
Fever 0.796 (0.700–
0.871)
0.848 (0.799–
0.889)
Amputation: one limb 0.134 (0.072–
0.223)
0.117 (0.078–
0.168)
Frequent veterinary visits (for fearful dogs) 0.244 (0.185–
0.310)
0.223 (0.186–
0.264)
Frequent subcutaneous injections by carers at home 0.555 (0.455–
0.652)
0.551 (0.484–
0.616)
Death 0.562 (0.460–
0.659)
0.558 (0.491–
0.624)
Legends: IWWs range from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable). The two sets of
IWWs were anchored by visual analogue scale (VAS) and time trade-off (TTO), respectively, after excluding the
anchoring welfare impediment “respiratory distress” in the model building process.
https://doi.org/10.1371/journal.pone.0202580.t006
Table 7. Years lived with impaired welfare (YLIWs), non-weighted and weighted (with the impaired welfare weight of death) years of life lost (YLLs) due to prema-
ture death and non-weighted and weighted welfare-adjusted life years (WALY) for 10 canine diseases.
Variable YLIW Non-weighted YLLs Non-weighted WALYs Weighted YLLs Weighted WALYs
Mitral valve disease 0.81 (0.14–1.70) 3.11 (1.10–7.08) 3.91 (1.80–7.67) 1.73 (0.60–3.98) 2.54 (1.21–4.61)
Dilated cardiomyopathy 0.31 (0.10–0.60) 7.09 (5.85–8.33) 7.40 (6.21–8.60) 3.96 (3.14–4.84) 4.27 (3.47–5.13)
Chronic kidney disease 0.58 (0.29–0.84) 3.52 (1.10–8.76) 4.11 (1.59–9.33) 1.97 (0.59–4.92) 2.55 (1.08–5.51)
Diabetes mellitus 1.00 (0.90–1.17) 3.62 (1.13–7.34) 4.62 (2.15–8.34) 2.02 (0.64–4.13) 3.02 (1.63–5.12)
Atopic dermatitis 9.73 (7.17–11.8) 0.00 (0.00–0.00) 9.73 (7.17–11.8) 0.00 (0.00–0.00) 9.73 (7.17–11.8)
Splenic haemangiosarcoma 0.49 (0.46–0.52) 4.36 (2.59–6.23) 4.85 (3.08–6.72) 2.43 (1.42–3.55) 2.93 (1.92–4.04)
Appendicular osteosarcoma 0.94 (0.67–1.30) 6.00 (2.90–9.90) 6.94 (3.83–10.84) 3.35 (1.60–5.59) 4.29 (2.52–6.55)
Cranial cruciate ligament disease 3.47 (2.39–4.58) 0.00 (0.00–0.00) 3.47 (2.39–4.58) 0.00 (0.00–0.00) 3.47 (2.39–4.58)
Thoracolumbar intervertebral disc disease 2.51 (1.37–3.51) 0.32 (0.16–0.45) 2.83 (1.54–3.94) 0.18 (0.09–0.26) 2.69 (1.47–3.75)
Cervical spondylomyelopathy 2.23 (1.67–3.17) 4.26 (2.28–6.63) 6.49 (4.55–8.76) 2.38 (1.26–3.76) 4.61 (3.40–6.00)
The impaired welfare weights were anchored by time trade-off (TTO) after excluding the impaired welfare weight of welfare impediment “respiratory distress” in the
model building process.
https://doi.org/10.1371/journal.pone.0202580.t007
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IWWs for 35 associated welfare impediments. These approaches revealed recommendations
that are expected to improve future applications of the methodology.
There are some important differences between the DALY and WALY assessments. Firstly,
DALY focuses more on population disease burden whereas WALY puts more emphasis on
individual animal welfare. That said, population-level WALYs can be calculated by multiplying
the number of cases in a certain population. Secondly, in WALY, we intended to quantify
“impaired welfare” instead of “impaired health”, as is used in DALYs. There is a notable differ-
ence in the definition of health between humans and animals. For human health, the WHO
definition is “a state of complete physical, mental and social well-being and not merely the
absence of disease or infirmity” [54]. Yet health in veterinary contexts is not well characterised
and generally focuses on physical functionality [55]. The health of animals is considered a cru-
cial component of welfare and so is not commonly considered the same as well-being (i.e., wel-
fare), as it is in humans [56]. Therefore, in the context of non-human animals, “welfare”
captures more negative impacts from diseases or other causes than “health” alone does.
As we tried to quantify the impairment of welfare instead of the impairment of health, one
philosophical question arose: can “death” be a welfare impediment and where should it be
located on the spectrum of welfare impediments? In DALYs, death is not a health state as it
represents a total loss of health. However, there are situations when people consider death is
better than being alive and terminate their life via voluntary euthanasia [57]. In the EuroQol- 5
dimensions questionnaire, an instrument widely used to evaluate health-related quality of life
in humans, “health state(s) worse than death” is a complex, and largely unresolved, issue [27,
58]. Therefore, in the current study, death was included as a welfare impediment such that the
Fig 2. The composition of non-weighted welfare-adjusted life years for 10 canine diseases. The impaired welfare weights were
anchored by time trade-off after excluding the impaired welfare weight of welfare impediment “respiratory distress” in the model
building process. YLIWs: Years lived with impaired welfare; YLLs: years of life lost; AD: atopic dermatitis; DCM: dilated
cardiomyopathy; AO: appendicular osteosarcoma; CSM: cervical spondylomyelopathy; SH: splenic haemangiosarcoma; DM: diabetes
mellitus; CKD: chronic kidney disease; MVD: mitral valve disease; CCLD: cranial cruciate ligament disease; TIDD: thoracolumbar
intervertebral disc disease.
https://doi.org/10.1371/journal.pone.0202580.g002
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current weighted YLLs and weighted WALYs incorporate the IWW of death. Interestingly,
death emerged with an IWW of approximately 0.56. As an IWW of 0 is the optimal welfare
imaginable and 1 is the worst welfare that one can imagine, a value close to 0.5 might reflect
the notion that death is a neutral welfare impediment where positive and negative experiences
are equally balanced (both zero in the case of death). However, because death is often seen as
more of an ethical than a welfare issue [59], we estimated weighted YLLs and WALYs only for
the purpose of encouraging discussion.
There are two distinct types of health/welfare impediments that can be used in DALY/
WALY, namely cause-specific and generic. Cause-specific welfare impediments mean that
each cause is one welfare impediment, while generic welfare impediments, such as the welfare
impediments in the current study, are not specific to a single cause and can result from several
causes. Both cause-specific and generic welfare impediments have their advantages. WALY
calculations using cause-specific welfare impediments require less input because each disease
has one only welfare impediment. Also, in the companion animal field, corresponding epide-
miological frequency and/or duration data for diseases are more abundant and detailed than
signs of diseases. However, there are two main concerns associated with the use of cause-spe-
cific welfare impediments. The first is the putative influence of the disease label (i.e., the name
of the disease) on people’s responses. Stouthard et al. (2000) reported an instance when, for
two diseases with similar health profiles, people judged the severity of the diseases differently
upon seeing their disease labels [60]. This indicates that disease labels provide information that
does not necessarily reflect the true state of the patient’s health but can affect health evaluation.
Secondly, IWWs of the cause-specific welfare impediments may need to be measured repeat-
edly because the welfare compromises caused by these diseases might lessen with advances in
medicine over time. In contrast, WALY calculation using the IWWs of generic welfare impedi-
ments requires only an update of the duration and prevalence of the welfare impediments.
Unlike cause-specific welfare impediments where the scale of the welfare impediments is con-
sistent, the scale of generic welfare impediments can vary because some, such as “severe heart
failure (with treatment)”, involve multiple signs, whereas others are just a single sign. The
same proviso applies to the health states in the GBD 2010 and 2013, so it does not concern us
excessively, especially because the evaluation standards for welfare compromise in the current
study were consistent across all the welfare impediments. Generation of a single weight for a
cause-specific or generic welfare impediment can over-simplify the severity of the welfare
impediment. Whether or not the IWW generated in the current report reflects the actual wel-
fare impact partially relies on the acumen of the researchers and the experts consulted.
The current study adopted the methodology used in the generation of disability weights for
health states in GBD 2010 and 2013 and it elicited IWWs based on data from paired compari-
son questions along with anchoring methods, visual analogue scale and time trade-offs. It is
prudent to note that the WALY measures animal welfare as perceived by humans (in this case
veterinarians), and not as perceived by the animals, i.e., dogs in the current study. In the cur-
rent study, the visual analogue scale and time trade-off were selected as the anchoring methods
for several reasons. A visual analogue scale is often used in disability weight generation in
DALY [61] and is relatively straightforward, compared with trade-off methods. Although it
has been reported that visual analogue scales generate higher disability weights than other
methods, including time trade-off, and relatively high disability weights for mild conditions
[62], this outcome was not observed in the current study when the IWWs anchored by the
visual analogue scale were compared with those anchored by time trade-off. Trade-off meth-
ods share a degree of cognitive complexity which, in the current study, was confirmed firstly
by the feedback from some participants about the time trade-off module and, secondly, by the
wider range and variance across the five IWWs elicited by time trade-off than those by visual
Welfare-Adjusted Life Years (WALY)
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analogue scale. However, the IWWs rescaled by time trade-off and those rescaled by visual
analogue scale were fairly similar. A possible inherent problem with time trade-off may be that
people value future life at a lower rate than current life [19]. However, this may be less of a con-
cern in the current study than in studies of human health states that have used time trade-off
to generate disability weights because people are less likely to put themselves fully into the
dogs’ position. One limitation emerged with the design of the time trade-off questions in the
current study: Although trade-off questions were hypothetical, it was virtually impossible to
imagine dogs with some of the welfare impediments, such as “respiratory distress”, in the time
trade-off module having to live for 10 years. We suggest future studies consider using the pop-
ulation health equivalence, a different trade-off anchoring method that asks participants to
judge the overall population health benefits produced by two different preventative programs
[23] or reducing the putative length of time if using time trade-off.
Some results of the current study ran counter to our expectations. The ranking of the
IWWs for “respiratory distress” and “cancer: lung metastasis with/without having metastasis
in other parts of the body” differed between the paired comparison results and results from
both visual analogue scale and time trade-off modules. Logical inconsistency, that is, the situa-
tion when worse welfare/health states are valued as less severe than better welfare/health states,
has also occurred in the EuroQol- 5 dimensions questionnaire. Such logical inconsistency has
been observed primarily among male, older, less-educated and religious participants in studies
of human health states conducted in Spain, Netherland and China [63–65]. Moreover, when
an interview is needed for the valuation, the risk of logical inconsistency is also associated with
interviewers’ performance and the interview process [65]. We judged that visual analogue
scale and time trade-off reflected the true rankings better than paired comparison. On the
visual analogue scale, the five welfare impediments were compared directly, and, in time
trade-off, participants were likely to compare the five welfare impediments when contemplat-
ing the period to be traded-off. In contrast, the variety of comparisons of welfare impediments
in the paired comparison module is much greater than the comparisons in the visual analogue
scale and the time trade-off modules, and is comparatively indirect. Additionally, as with
many questionnaires, there may be a so-called learning curve for participants as they engaged
with the various stages of the current survey. Because the participants started with paired com-
parison questions, followed by the visual analogue and time trade-off, the pattern of compari-
sons would have been more consistent later than earlier. Similarly (and surprisingly), the
IWW was higher in “overweight” than in “obesity,” and higher in “spinal hyperesthesia: mild”
than in “spinal hyperesthesia: severe.” As paired comparison methodology has been used to
generate disability weights in various studies [23, 66, 67], and we were content that the severity
of any welfare compromise was discernible from the lay descriptions when compared directly,
the limited combinations of paired comparison questions used in the questionnaires are likely
to be responsible for these unexpected results. In GBD, an algorithm was used for the random
selection of health states for paired comparison questions, so combinations of paired compari-
son questions in that device were unlimited [23]. In contrast, the current study offered limited
combinations of the paired comparison questions which might inadvertently impose a pattern
of responses resulting in a systemic error. We suggest an algorithm allowing random selection
of paired comparison questions should be used in the future.
Because of the unattainability of verbal communication between human and non-human
animals, animal welfare evaluations are often vulnerable to a certain level of subjectivity on the
part of human evaluators [68]. IWW evaluation is not an exception. Many factors may influ-
ence the welfare evaluation, including the attitudes towards animal welfare and the ability to
judge the degree of welfare compromise accurately. Although many of those factors were
explored in the questionnaire, the current sample size was not generated specifically to identify
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the statistical difference in IWWs between different characteristics of the respondents. Never-
theless, some trends were observed. For example, anchoring IWW values were higher in
females than males. This finding is unsurprising, given that gender is often associated with atti-
tudes towards animals and animal welfare [24, 25] and females often show more empathy to
animals [25, 69]. Also, veterinarians who were younger or graduated recently perceived higher
IWWs for the five anchoring welfare impediments. This might relate directly to the length of
their time in practice which may inadvertently have a desensitising effect as less concern for
animal sentience has been shown among students in the higher years of veterinary study [24].
It is recognised that veterinarians continuously encounter ethical conflicts and moral distress
during practice [70]. So, counter-anthropomorphising, a process of assigning inanimate quali-
ties to living things, may distance them from those challenges and also desensitise them to
compromised welfare in animals around them [71]. On the other hand, more emphasis on ani-
mal welfare education in veterinary schools in recent years may have given recent graduates
more awareness of animal welfare and animal sentience than the older graduates, allowing
them to make a more knowledge-based evaluation [72, 73]. Moreover, as the veterinary profes-
sion is feminising [74], there is probably an ongoing interaction of gender and age. Veterinari-
ans working with livestock rated the five anchoring welfare impediments as less severe than
those not working with livestock. Farming has been found to be associated with instrumental
attitudes towards animals [25, 26]; an attitude that may have carried over to the dogs in the
current hypothetical cases. We acknowledge a likely interaction between working with live-
stock and gender because males in our study population were 1.3 times more likely to work
with livestock than females were.
Another factor potentially affecting the current values of IWWs is the source of the partici-
pants [75]. There are debates about the most suitable population from which to recruit partici-
pants to elicit disability weights [76]. Although an increasing number of studies that elicited
the disability weights for DALYs have been recruited from the general public [23, 66, 67], early
studies often targeted health professionals’ opinions [20, 77, 78]. This latter practice was criti-
cised because health professionals are likely to link the lay descriptions to specific disease labels
(whose inadvertent influence have been discussed above) and unintentionally to take into
account comorbidities of the diseases, resulting in an overestimation of disability weights [23].
Veterinarians were targeted for the current study, instead of lay dog owners, for two reasons.
Firstly, we expected lay dog owners to be equipped with less knowledge of animal welfare than
veterinarians. Secondly, it is more likely that lay dog owners would evaluate dog welfare
anthropomorphically. In the current study, more than 90% of the participants grew up with
dogs or had owned dogs, meaning that, beyond their clinical insights, they also understood
dog welfare from an owner’s perspective. However, it would be interesting to use the current
tool to elicit IWWs from lay dog owners and to compare them with those from veterinarians.
Paired comparison questions could be easily used in such a study, because they have been
shown to be comprehensible by people with various levels of education, in contrast to com-
monly used trade-off methods [23].
There are some more limitations of the current study that we wish to acknowledge. Firstly,
the sources of the published articles that were used to obtain the epidemiological information
for WALY calculation varied. As shown in Table 1, some articles were fairly old and so might
not depict the current situation, and some of the prevalence and duration of the welfare
impediments in the same disease were necessarily sourced from different articles. Additionally,
it is likely that the epidemiological information reported in some of these articles was not rep-
resentative of the general dog population as most of the articles used data from premium veter-
inary practices, particularly teaching hospitals. Ideally, all the epidemiological information
should come from the same population of dogs, temporally and spatially. Data from well-
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constructed companion animal databases, such as VetCompass in the UK [79] and Australia
[80] and Agria insurance company in Sweden [81], would be needed to achieve such goals.
Secondly, as the evaluation of the IWWs was based on the impact on dogs’ biological function-
ing evaluated by veterinarians instead of their emotive states, dogs might not necessarily prefer
a welfare impediment with lower IWW. Thirdly, the prospects of comorbidity were not
embraced in this study. These merit consideration. On the one hand, it is likely that the total
welfare compromise caused by having both welfare impediment “A” and welfare impediment
“B” concurrently may not amount to a simple summation of their welfare compromise. On the
other hand, we did not embed methods to account for conflated welfare impediments in ani-
mals with more than one disease that have the same welfare impediments. In this case, the
YLIWs for affected animals would be overestimated. The sample size needs to be larger to
account for potential confounders, such as gender and age, and to allow the consideration of
the variability of the anchoring IWWs in the probit model. Fourthly, the mortality caused by
euthanasia in atopic dermatitis and cranial cruciate ligament disease was not factored into the
current WALY calculations due to the unavailability of the relevant information in the litera-
ture. Lastly, although the methods used to elicit IWWs have been validated in GBD 2010 and
2013 [23, 66], validation of the current approach to (companion) animals is needed.
The WALY approach has shown promise in the current pilot and may have extensive appli-
cations. Firstly, the methodology allows welfare compromise and total disease impact of all
sorts of diseases to be quantified and compared. It has the potential to inform prioritisation of
research into prevention of and interventions for the diseases that have more adverse effects.
Also, analyses of the cost-effectiveness of disease prevention merit exploration. Secondly,
WALYs can also be estimated for populations. WALYs for diseases can be calculated for differ-
ent sex, breed, age groups and geographical regions and then compared. This is particularly
useful for determining the total impact of diseases in different breeds of dogs [18]. A quantita-
tive exploration of breeds with poor welfare as a result of greater disease burden can be accom-
plished by comparing the summated WALY values of common diseases for different breeds of
dogs. However, even for an identical welfare impediment, the welfare compromises can vary
among breeds and, especially among different sizes and shapes of dogs. For instance, anec-
dotally, the welfare of paralysed large dogs is much worse than paralysed small dogs, and they
require more care from humans than paralysed small dogs do. This may need to be factored
into further considerations of IWW. Thirdly, the WALY would allow monitoring of changes
in the welfare and disease impact of a given population over time. Fourthly, WALYs can be cal-
culated not only for the impact of diseases but also of other welfare issues, such as long-term
confinement, training interventions or undesirable behaviours. Lastly, although we demon-
strated the WALY framework with diseases in dogs, it can also be adapted for use in other
companion and production animals. However, if using WALY metric for other species of ani-
mal, the unit of time may need to be changed from year to a unit of time more suitable for that
species, depending on the expected lifespan of the species and the usage of the animal in
human contexts. The expected lifespan in production animals would then be the time from
birth to slaughter or culling. Instead of units of time, using the proportion of life affected will
enable the comparison across species.
Conclusion
This study developed the WALY metric by adapting the DALY approach from the GBD stud-
ies. The approach was implemented for 10 common canine diseases that not only enabled us
to estimate IWWs and WALYs but also allowed the identification of potential issues that could
affect this calculation and could be improved upon in the future.
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The WALY could become a powerful metric to summarise welfare compromise and disease
impact of individual diseases in companion and production animals. Future potential applica-
tions of the WALY are extensive and may include prioritisation of disorders for eradication
and control, quantification of population welfare and longitudinal surveillance of animal
welfare.
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